UAECell19

UAECell19 Uses, Dosage, Side Effects, Food Interaction and all others data.

Autologous non-hematopoietic peripheral blood stem cells have been created into a formulation for use in a clinical trial (NCT04473170) by the Abu Dhabi Stem Cells Center. The cells have the characterizations of CD90+, CD133+, Oct-4+, CD45-, and CD71-.

Trade Name UAECell19
Generic Autologous Non-Hematopoietic Peripheral Blood Stem Cells
Autologous Non-Hematopoietic Peripheral Blood Stem Cells Other Names NHPBSC, UAECell19
Type
Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: September 19, 2023 at 7:00 am
UAECell19
UAECell19

Innovators Monograph

You find simplified version here UAECell19


*** Taking medicines without doctor's advice can cause long-term problems.
Share